Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Plus Gemcitabine in Stage II/III Breast Cancer
NCT00532285Phase 2Terminated
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel, gemcitabine in breast cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Sep 2005; status: terminated.
02
Drugs
paclitaxelgemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00532285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532285.